{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:01:45Z","timestamp":1793325705668,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Royal Library, Copenhagen University Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims\/hypothesis<\/jats:title>\n                <jats:p>Fragility fractures may be a complication of diabetes, partly caused by chronic hyperglycaemia. We hypothesised that: (1) individuals with hyperglycaemia and diabetes have increased risk of fragility fracture; (2) hyperglycaemia is causally associated with increased risk of fragility fracture; and (3) diabetes and fragility fracture jointly associate with the highest risk of all-cause mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In total, 117,054 individuals from the Copenhagen City Heart Study and the Copenhagen General Population Study (the Copenhagen studies) and 390,374 individuals from UK Biobank were included for observational and one-sample Mendelian randomisation (MR) analyses. Fragility fractures were defined as fractures at the hip, spine and arm (humerus\/wrist), collected from national health registries. Summary data for fasting glucose and HbA<jats:sub>1c<\/jats:sub> concentrations from 196,743 individuals in the Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) were combined with data on fragility fractures from the Copenhagen studies in two-sample MR analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Higher fasting and non-fasting glucose and HbA<jats:sub>1c<\/jats:sub> concentrations were associated with higher risk of any fragility fracture (<jats:italic>p<\/jats:italic>&lt;0.001). Individuals with vs without diabetes had HRs for fragility fracture of 1.50 (95% CI 1.19, 1.88) in type 1 diabetes and 1.22 (1.13, 1.32) in type 2 diabetes. One-sample MR supported a causal association between high non-fasting glucose concentrations and increased risk of arm fracture in the Copenhagen studies and UK Biobank combined (RR 1.41 [1.11, 1.79], <jats:italic>p<\/jats:italic>=0.004), with similar results for fasting glucose and HbA<jats:sub>1c<\/jats:sub> in two-sample MR analyses (ORs 1.50 [1.03, 2.18], <jats:italic>p<\/jats:italic>=0.03; and 2.79 [1.12, 6.93], <jats:italic>p<\/jats:italic>=0.03, respectively). The corresponding MR estimates for any fragility fracture were 1.18 (1.00, 1.41), <jats:italic>p<\/jats:italic>=0.06; 1.36 (0.89, 2.09), <jats:italic>p<\/jats:italic>=0.15; and 2.47 (0.95, 6.43), <jats:italic>p<\/jats:italic>=0.06, respectively. At age 80 years, cumulative death was 27% in individuals with fragility fracture only, 54% in those with diabetes only, 67% in individuals with both conditions and 17% in those with neither.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions\/interpretation<\/jats:title>\n                <jats:p>Hyperglycaemia and diabetes are risk factors for fragility fracture and one- and two-sample MR analyses supported a causal effect of hyperglycaemia on arm fractures. Diabetes and previous fragility fracture jointly conferred the highest risk of death in the general population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00125-023-06054-8","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T11:02:30Z","timestamp":1702551750000},"page":"301-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Hyperglycaemia, diabetes and risk of fragility fractures: observational and Mendelian randomisation studies"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-2847","authenticated-orcid":false,"given":"Frida","family":"Emanuelsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1442-4694","authenticated-orcid":false,"given":"Shoaib","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9624-5210","authenticated-orcid":false,"given":"Niklas R.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1954-7220","authenticated-orcid":false,"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1701-595X","authenticated-orcid":false,"given":"Marianne","family":"Benn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"issue":"5","key":"6054_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/aje\/kwm106","volume":"166","author":"M Janghorbani","year":"2007","unstructured":"Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166(5):495\u2013505. https:\/\/doi.org\/10.1093\/aje\/kwm106","journal-title":"Am J Epidemiol"},{"issue":"1","key":"6054_CR2","doi-asserted-by":"publisher","first-page":"e024067","DOI":"10.1136\/bmjopen-2018-024067","volume":"9","author":"H Wang","year":"2019","unstructured":"Wang H, Ba Y, Xing Q, Du J-L (2019) Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis. BMJ Open 9(1):e024067. https:\/\/doi.org\/10.1136\/bmjopen-2018-024067","journal-title":"BMJ Open"},{"issue":"3","key":"6054_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S2213-8587(21)00347-8","volume":"10","author":"LC Hofbauer","year":"2022","unstructured":"Hofbauer LC, Busse B, Eastell R et al (2022) Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diabetes Endocrinol 10(3):207\u2013220. https:\/\/doi.org\/10.1016\/S2213-8587(21)00347-8","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"6054_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00592-018-1101-7","volume":"55","author":"C Conte","year":"2018","unstructured":"Conte C, Epstein S, Napoli N (2018) Insulin resistance and bone: a biological partnership. Acta Diabetol 55(4):305\u2013314. https:\/\/doi.org\/10.1007\/s00592-018-1101-7","journal-title":"Acta Diabetol"},{"key":"6054_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S2213-8587(17)30134-1","volume":"5","author":"D Vikram","year":"2017","unstructured":"Vikram D, Shanbhogue V, Shanbhogue VV et al (2017) Bone disease in diabetes: another manifestation of microvascular disease? Lancet Diabetes Endocrinol 5:827\u2013865. https:\/\/doi.org\/10.1016\/S2213-8587(17)30134-1","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"6054_CR6","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1210\/jcem.87.7.8660","volume":"87","author":"JA Clowes","year":"2002","unstructured":"Clowes JA, Robinson RT, Heller SR, Eastell R, Blumsohn A (2002) Acute changes of bone turnover and PTH induced by insulin and glucose: euglycemic and hypoglycemic hyperinsulinemic clamp studies. J Clin Endocrinol Metab 87(7):3324\u20133329. https:\/\/doi.org\/10.1210\/jcem.87.7.8660","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"6054_CR7","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1093\/cvr\/cvy045","volume":"114","author":"M Benn","year":"2018","unstructured":"Benn M, Nordestgaard BG (2018) From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment. Cardiovasc Res 114(9):1192\u20131208. https:\/\/doi.org\/10.1093\/cvr\/cvy045","journal-title":"Cardiovasc Res"},{"issue":"8","key":"6054_CR8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133\u20131163. https:\/\/doi.org\/10.1002\/sim.3034","journal-title":"Stat Med"},{"issue":"25","key":"6054_CR9","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.jacc.2012.02.043","volume":"59","author":"M Benn","year":"2012","unstructured":"Benn M, Tybj\u00e6rg-Hansen A, McCarthy MI, Jensen GB, Grande P, Nordestgaard BG (2012) Nonfasting glucose, ischemic heart disease, and myocardial infarction. J Am Coll Cardiol 59(25):2356\u20132365. https:\/\/doi.org\/10.1016\/j.jacc.2012.02.043","journal-title":"J Am Coll Cardiol"},{"key":"6054_CR10","unstructured":"UK Biobank Coordinating Centre (2007) Protocol for a large-scale prospective epidemiological resource. Available from https:\/\/www.ukbiobank.ac.uk\/media\/gnkeyh2q\/study-rationale.pdf. Accessed 30 October 2023"},{"issue":"9","key":"6054_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ng.2385","volume":"44","author":"RA Scott","year":"2012","unstructured":"Scott RA, Lagou V, Welch RP et al (2012) Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 44(9):991\u20131005. https:\/\/doi.org\/10.1038\/ng.2385","journal-title":"Nat Genet"},{"issue":"4","key":"6054_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00125-010-2038-8","volume":"54","author":"ML Hribal","year":"2011","unstructured":"Hribal ML, Presta I, Procopio T et al (2011) Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B. Diabetologia 54(4):795\u2013802. https:\/\/doi.org\/10.1007\/s00125-010-2038-8","journal-title":"Diabetologia"},{"issue":"2","key":"6054_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/ng.520","volume":"42","author":"J Dupuis","year":"2010","unstructured":"Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42(2):105\u2013116. https:\/\/doi.org\/10.1038\/ng.520","journal-title":"Nat Genet"},{"key":"6054_CR14","doi-asserted-by":"publisher","unstructured":"Swerdlow DI, Kuchenbaecker KB, Shah S et al (2016) Selecting instruments for Mendelian randomization in the wake of genome-wide association studies. Int J Epidemiol 1600\u20131616. https:\/\/doi.org\/10.1093\/ije\/dyw088","DOI":"10.1093\/ije\/dyw088"},{"issue":"25","key":"6054_CR15","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/eurheartj\/ehv108","volume":"36","author":"BK Lauridsen","year":"2015","unstructured":"Lauridsen BK, Stender S, Frikke-Schmidt R, Nordestgaard BG, Tybj\u00e6rg-Hansen A (2015) Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease. Eur Heart J 36(25):1601\u20131608. https:\/\/doi.org\/10.1093\/eurheartj\/ehv108","journal-title":"Eur Heart J"},{"issue":"4","key":"6054_CR16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2337\/dc19-1850","volume":"43","author":"F Emanuelsson","year":"2020","unstructured":"Emanuelsson F, Marott S, Tybj\u00e6rg-Hansen A, Nordestgaard BG, Benn M (2020) Impact of glucose level on micro- and macrovascular disease in the general population: a mendelian randomization study. Diabetes Care 43(4):894\u2013902. https:\/\/doi.org\/10.2337\/dc19-1850","journal-title":"Diabetes Care"},{"issue":"2","key":"6054_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41588-018-0302-x","volume":"51","author":"JA Morris","year":"2019","unstructured":"Morris JA, Kemp JP, Youlten SE et al (2019) An atlas of genetic influences on osteoporosis in humans and mice. Nat Genet 51(2):258\u2013266. https:\/\/doi.org\/10.1038\/s41588-018-0302-x","journal-title":"Nat Genet"},{"issue":"6","key":"6054_CR18","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41588-021-00852-9","volume":"53","author":"J Chen","year":"2021","unstructured":"Chen J, Spracklen CN, Marenne G et al (2021) The trans-ancestral genomic architecture of glycemic traits. Nat Genet 53(6):840\u2013860. https:\/\/doi.org\/10.1038\/s41588-021-00852-9","journal-title":"Nat Genet"},{"issue":"5","key":"6054_CR19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","volume":"54","author":"A Mahajan","year":"2022","unstructured":"Mahajan A, Spracklen CN, Zhang W et al (2022) Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat Genet 54(5):560\u2013572. https:\/\/doi.org\/10.1038\/s41588-022-01058-3","journal-title":"Nat Genet"},{"issue":"4","key":"6054_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2337\/db19-0831","volume":"69","author":"V Forgetta","year":"2020","unstructured":"Forgetta V, Manousaki D, Istomine R et al (2020) Rare genetic variants of large effect influence risk of type 1 diabetes. Diabetes 69(4):784\u2013795. https:\/\/doi.org\/10.2337\/db19-0831","journal-title":"Diabetes"},{"issue":"1","key":"6054_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1536867X0300300101","volume":"3","author":"C Baum","year":"2003","unstructured":"Baum C, Schaffer M, Stillman S (2003) Instrumental variables and GMM: estimation and testing. Stata J 3(1):1\u201331. https:\/\/doi.org\/10.1177\/1536867X0300300101","journal-title":"Stata J"},{"key":"6054_CR22","unstructured":"Nichols A (2007) IVPOIS: Stata module to estimate an instrumental variables Poisson regression via GMM. Statistical Software Components. S456890, Boston College Department of Economics; revised 3 Sep 2008"},{"key":"6054_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, CRP CHD Genetics Collaboration (2011) Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 40:755\u2013764. https:\/\/doi.org\/10.1093\/ije\/dyr036","journal-title":"Int J Epidemiol"},{"issue":"7414","key":"6054_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"issue":"2","key":"6054_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11914-007-0004-2","volume":"5","author":"D Vashishth","year":"2007","unstructured":"Vashishth D (2007) The role of the collagen matrix in skeletal fragility. Curr Osteoporos Rep 5(2):62\u201366. https:\/\/doi.org\/10.1007\/s11914-007-0004-2","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"6054_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2337\/dc20-1220","volume":"44","author":"GS Davie","year":"2021","unstructured":"Davie GS, Pal K, Orton E, Tyrrell EG, Petersen I (2021) Incident type 2 diabetes and risk of fracture: a comparative cohort analysis using U.K. primary care records. Diabetes Care 44(1):58\u201366. https:\/\/doi.org\/10.2337\/dc20-1220","journal-title":"Diabetes Care"},{"issue":"4","key":"6054_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis. Osteoporos Int 18(4):427\u2013444. https:\/\/doi.org\/10.1007\/s00198-006-0253-4","journal-title":"Osteoporos Int"},{"issue":"3","key":"6054_CR28","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/cen.14501","volume":"95","author":"H Li","year":"2021","unstructured":"Li H, Wen Y, Liu P et al (2021) Characteristics of bone metabolism in postmenopausal women with newly diagnosed type 2 diabetes mellitus. Clin Endocrinol (Oxf) 95(3):430\u2013438. https:\/\/doi.org\/10.1111\/cen.14501","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"13","key":"6054_CR29","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.jacc.2017.08.006","volume":"70","author":"BG Nordestgaard","year":"2017","unstructured":"Nordestgaard BG (2017) A test in context: lipid profile, fasting versus nonfasting. J Am Coll Cardiol 70(13):1637\u20131646. https:\/\/doi.org\/10.1016\/j.jacc.2017.08.006","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6054_CR30","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"M-JA Brion","year":"2013","unstructured":"Brion M-JA, Shakhbazov K, Visscher PM (2013) Calculating statistical power in Mendelian randomization studies. Int J Epidemiol 42(5):1497\u20131501. https:\/\/doi.org\/10.1093\/ije\/dyt179","journal-title":"Int J Epidemiol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-06054-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-023-06054-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-06054-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T08:03:51Z","timestamp":1705305831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-023-06054-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["6054"],"URL":"https:\/\/doi.org\/10.1007\/s00125-023-06054-8","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We thank participants and staff of the Copenhagen City Heart Study, the Copenhagen General Population Study, UK Biobank and the Meta-Analyses of Glucose and Insulin-related traits Consortium for their generous participation. This research has been conducted using the UK Biobank Resource under Application Number 81614.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"Aggregated data from the Copenhagen City Heart Study and the Copenhagen General Population Study may be available on reasonable request to the corresponding author. UK Biobank is a publicly available resource, available upon application to UK Biobank. Summary data from the Meta-Analyses of Glucose and Insulin-related traits Consortium are publicly available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Open access funding provided by Royal Library, Copenhagen University Library. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"BGN reports consultancies\/talks for AstraZeneca, Sanofi, Regeneron, Ionis, Amgen, Kowa, Denka, Amarin, Novartis, Novo Nordisk, Esperion, Abbott, Silence Therapeutics, Ultragenyx, Mankind and Lilly. The other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"MB and FE conceptualised the study. MB, BGN, SA and FE contributed to data collection, data preparation or both. FE and MB did the statistical analyses and FE drafted the manuscript. All authors\u00a0contributed substantially to study design and data interpretation, and reviewed the manuscript for important intellectual content. All authors had full access to all the data in the study and have approved the final version of the manuscript for publication. MB is the guarantor of this work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}